EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interplay of IL‐6, GDF‐15 and Sarcopenia in Patients With Bladder Cancer Undergoing Radical Cystectomy and Its Implications on Survival

Simon U Engelmann, Felix Kasparbauer, Christoph Pickl, Francesco Del Giudice, Maximilian Haas, Emily Rinderknecht, Peter J Siska, Renate Pichler, Christoph Niessen, Maximilian Burger, Miodrag Gužvić, Roman Mayr iD

Journal of Cachexia, Sarcopenia and Muscle · 2025-12 · 16 (6)

DOI: 10.1002/jcsm.70146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 11.12.2025. Verfasst von Simon U Engelmann und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, St. Josef Medical Center, University of Regensburg, Regensburg, Germany. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Sarcopenia, Cystectomy, Interleukin-6. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia has emerged as a significant predictor of adverse outcomes in cancer. Specifically, this is also true for patients with bladder cancer undergoing radical cystectomy (RC). This retrospective study investigates the roles of the biomarkers interleukin‐6 (IL‐6) and growth differentiation factor‐15 (GDF‐15), in the context of sarcopenia, assessing their impact on oncological and survival outcomes.

Methods

Preoperative serum IL‐6 and GDF‐15 levels were analysed in 179 patients undergoing RC. Their association with sarcopenia, adverse pathological features and survival outcomes was investigated.

Results

Elevated IL‐6 and GDF‐15 levels were significantly correlated with the presence of sarcopenia ( p = 0.04 and p = 0.03, respectively). IL‐6 and GDF‐15 levels in serum showed a positive correlation (Spearman r = 0.45, 95%CI 0.32–0.56, p < 0.01). Higher IL‐6 and GDF‐15 levels were also associated with higher tumour stages (both p < 0.01), positive lymph nodes ( p = 0.02 and p < 0.01) and unfavourable surgical margins (both p < 0.01). Patients with both sarcopenia and high IL‐6 or GDF‐15 levels exhibited significantly worse overall survival and cancer‐specific survival in multivariate Cox regression analysis.

Conclusions

These findings highlight the interplay between IL‐6, GDF‐15, sarcopenia and tumour progression, suggesting that IL‐6 and GDF‐15 may serve as valuable prognostic biomarkers and potential therapeutic targets. Further research is warranted to explore targeted therapeutic strategies aimed at mitigating sarcopenia and systemic inflammation in this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsSarcopeniaCystectomyInterleukin-6Growth Differentiation Factor 15Prospective StudiesHumansMaleFemaleAgedRetrospective StudiesProportional Hazards ModelsSurvival RateNeoplasm StagingPrognosis

Stichwörter der Autor:innen

GDF‐15biomarkersbladder cancerinterleukin 6sarcopeniaurothelial cancer

Substanzen

IL6 protein, humanInterleukin-6GDF15 protein, humanGrowth Differentiation Factor 15

Autor:innen und Institutionen

  • Department of Urology, St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • Department of Maternal-Infant and Urological Sciences, Sapienza Rome University, Rome, Italy.
  • Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Department of Urology, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.
  • Department of Radiology, St. Josef Medical Center, Regensburg, Germany.

ORCID-Profile: Roman Mayr

Zitieren

APA

Engelmann, S. U., Kasparbauer, F., Pickl, C., Del Giudice, F., Haas, M., Rinderknecht, E., Siska, P. J., Pichler, R., Niessen, C., Burger, M., Gužvić, M., & Mayr, R. (2025). Interplay of IL‐6, GDF‐15 and Sarcopenia in Patients With Bladder Cancer Undergoing Radical Cystectomy and Its Implications on Survival. Journal of Cachexia, Sarcopenia and Muscle, 16(6). https://doi.org/10.1002/jcsm.70146

Vancouver

Engelmann SU, Kasparbauer F, Pickl C, Del Giudice F, Haas M, Rinderknecht E, et al. Interplay of IL‐6, GDF‐15 and Sarcopenia in Patients With Bladder Cancer Undergoing Radical Cystectomy and Its Implications on Survival. Journal of Cachexia, Sarcopenia and Muscle. 2025;16(6). doi:10.1002/jcsm.70146

BibTeX
@article{Engelmann2025,
  author = {Engelmann, Simon U and Kasparbauer, Felix and Pickl, Christoph and Del Giudice, Francesco and Haas, Maximilian and Rinderknecht, Emily and Siska, Peter J and Pichler, Renate and Niessen, Christoph and Burger, Maximilian and Gužvić, Miodrag and Mayr, Roman},
  title = {Interplay of IL‐6, GDF‐15 and Sarcopenia in Patients With Bladder Cancer Undergoing Radical Cystectomy and Its Implications on Survival},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  volume = {16},
  number = {6},
  doi = {10.1002/jcsm.70146}
}
Kostenlos starten →